Skip to content
People

John Lepping

Director at Linnaeus Therapeutics.

Earliest Form D on file: Feb 2026

Linnaeus Therapeutics

Haddonfield NJ

Director

  • Signed
  • Named
  • Amendment
  • Size is amount sold

Filings

4 filings · 1 offering
  • Feb 27, 2026

    Equity, named · Form D

    $4.992M

    of $10M

    3 amendmentsLatest Apr 2, 2026

Network

At Linnaeus Therapeutics

6 people